Healthcare and Life Sciences

Format: 2016-09-30
Format: 2016-09-30
September 30, 2016 | 83 Pages | SKU: IRTNTR10362

Global market overview for baby warming devices

Technavio’s market research analysts have estimated that the global market for baby warming devices will grow at an impressive CAGR of almost 9% by 2020. Factors like the increasing incidence of Preterm births will result in the high need for better fetal and neonatal care facilities. According to a research, Preterm births account for 5 to 18% of overall childbirths worldwide, and it is estimated that every year more than 15 million babies are born Preterm, of which more than one million infants die from premature birth complications. Preterm infants face short- and long-term complications as their organ systems are immature and not prepared to support life in the extra-uterine environment. Such infants require warmth, breastfeeding support, and necessary care for infections and breathing difficulties, life support, and critical care monitoring. As a result, governments across the globe, especially in developing economies, are taking initiatives to develop better infrastructure and provide knowledge and awareness about pregnancy, neonatal care, and after complications caused during infancy stage.

Another factor impelling this market’s growth rate is the rising demand for portable devices among healthcare end-users. Portable devices offer excellent performance and eliminate the need for investing in a separate neonatal care system for each location. Portable neonatal warming devices are better than conventional devices as they help to increase thermal care for premature and low-weight babies. These devices offer a stable micro-climate, easy sanitization, and close mother-child interaction. According to this market research report,


September 30, 2016 | 134 Pages | SKU: IRTNTR10562

Overview of the autoimmune disease diagnostics market

The autoimmune disease diagnostics market is anticipated to grow at a steady state and will post a CAGR of more than 6% over the forecast period. The discovery of novel biomarkers is one of the major factors propelling the growth prospects of this market. With the development of novel biomarkers, there has been a significant improvement in the diagnosis of autoimmune diseases. The use of singular conventional biomarkers proves to be of little help as individuals with autoimmune diseases can develop multiple symptoms that can be difficult for the physicians to diagnose. Therefore, there is an increased demand for multiple biomarkers that could help identify and evaluate the patient status, disease type, and progression and response to therapy for autoimmune diseases. Moreover, the development of autoantibodies to a given protein is witnessed only in a few people with autoimmune disorders. This has led researchers to conduct extensive R&D activities that are showing positive results in the use of multiple biomarkers for the diagnosis of autoimmune diseases. The ability to screen an individual with multiple biomarkers associated with several autoimmune diseases has improved the disease diagnosis considerably.

In terms of geography, the Americas led the global autoimmune disease diagnostics market and will continue to dominate the market in the coming years. The growing incidence of autoimmune disorders such as RA, SLE, and IBD will aid in the growth of this market. Also, the extensive R&D activities has allowed the launch of novel diagnostic products, which


September 30, 2016 | 102 Pages | SKU: IRTNTR10476

Global outlook of the gastrointestinal therapeutics market

Technavio’s market research analysts predict the global gastrointestinal therapeutics market to grow steadily during the forecast period and will post a CAGR of more than 6% by 2020. This industry research report identifies the increasing consumption of biologics for inflammatory bowel diseases (IBD) to be one of the major factors that will have a positive impact on the growth of the gastrointestinal therapeutics market in the coming years. Biologics that are available as intravenous or subcutaneous injections, are the most preferred choices for the treatment of gastrointestinal diseases such as IBD. These therapeutics act by either blocking the interleukins or the TNF-α. HUMIRA, Remicade, and Cimzia, which are some anti-TNF agents whereas, Tysabri and ENTYVI are some of the anti-integrin agents available in the market for the treatment of conditions such as ulcerative colitis and Crohn's disease. In addition, several pharmaceutical companies are constantly making investments to develop advanced biologics for the treatment of IBD, which will further aid in the growth of the market over the predicted period.

The emergence of biosimilars will be one of the major trends that will gain traction in this market in the next four years. The increased usage of biologics will induce several countries


September 29, 2016 | 97 Pages | SKU: IRTNTR10275

Overview of the foot drop implants market

Extensive research carried out by the analysts at Technavio has shown that the global foot drop implants market will witness fast-paced growth and will post a staggering CAGR of more than 9% over the forecast period. One of the major factors fuelling the demand for foot drop implants is the growing incidence of diabetic neuropathy. The high blood sugar levels damage the nerve fibers throughout the body, which will lead to an augmented demand for foot drop implants. According to CDC 2014 statistics, nearly 29 million individuals in the US have diabetes, of which 26% of individuals with type 2 diabetes have witnessed a nerve damage during diagnosis.

The growing popularity of hammertoe implants is one of the recent trends gaining significant traction in the market. An estimated 500,000 surgical procedures are performed for the treatment of hammertoes each year. Hammertoe implants help in the fixation of bones in osteotomies and reconstruction of lesser toes. Several hammertoe implants are currently available in the market, such as Nextra Hammertoe Correction system offered by Nextremity Solutions consisting RevLock precision locking system that provides adjustability and versatility. Moreover, in December 2015, Instratek launched the ToeTac single-use kit for the operative repair of hammertoe deformities. The ToeTac implant includes two threaded ends that fix into the bone. The first end is a common bone thread and the second end is interrupted by slots that enable the implant to flex in response to insertion forces. This implant is designed to fit a range of anatomies, leading to its increased adoption over the estimated period


September 28, 2016 | 102 Pages | SKU: IRTNTR10337

Outlook of the regenerative medicine market in Japan

According to the market research analyst at Technavio, the regenerative medicine market in Japan will grow steadily and post a CAGR of approximately 35% by 2020. The relaxation of government regulations and new legislation for regenerative medicine will be one of the primary drivers for market growth and will help with safer and faster provision of the innovative products. The recent approvals from the Pharmaceutical Affairs Law for two CTBPs (C-terminal binding proteins) will help medical and clinical researchers to develop medicines and treatments for affected patients. Additionally, these advancements will help provide individuals with opportunities to obtain CTBPs treatments based on the latest scientific standard. In addition, the launch of various innovative regenerative medicines will aid in the growth of this market in Japan during the forecast period.

In the recent times, Japan has seen an emergence of 3D tissue bioprinters for the development of effective regenerative medicines. The 3D bioprinters allow the researchers to re-create skin, cartilage, blood vessels, and other complex human tissue. An increasing number of organizations are investing in the facilitation of new projects that use technologies like iPS cells and 3-D printers will lead to the growth of this market during the next few years.

Competitive landscape and key vendors

The relaxation of government regulations and advancements in regenerative therapy have resulted in the entry of new vendors in the market. However, the level of competition in the market will still be determined by the existing


September 28, 2016 | 60 Pages | SKU: IRTNTR10274

Overview of the fluoroscopy C-arms market

According to the market research analysts at Technavio, the global fluoroscopy C-arms market is anticipated to witness steady growth and will post a moderate CAGR of more than 4% over the forecast period. Advances in technology and upgradation in equipment is easing diagnostic procedures considerably, which is one of the major factors driving this market’s growth. In the field of medical imaging, new products with improved features and parameters are preferred by end-users across the globe. The latest fluoroscopy systems are equipped with high-quality image intensifiers and spectral shaping filters to provide high-clarity images. Moreover, radiation-reduction devices are attached to the existing fluoroscopy systems to make them safe for use by radiologists. In addition, installing inverter generators with medium frequency enables high-performance switching capability in fluoroscopy devices, which is leading to their increased adoption during the forecast period.

In terms of geography, the Americas led the global fluoroscopy C-arms market and is expected to continue its dominance over the coming years. The largest revenue contributor to this region was the US because of the growing elderly population and increased number of surgical procedures. Also, technological advancements in the areas of product design and application, as well as the availability of reimbursements from Medicare and the replacement of fluoroscopy and mobile C-arm components will contribute to this market’s growth in the region.

Competitive landscape and key vendors


Pages